Janwillem Kocks

Prof. Dr. Janwillem Kocks

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2011 in Primary Care Respiratory Journal
Verified
Journal Article
Closed access
TITsiligianni Ioanna
Tsiligianni Ioanna
JKJanwillem Kocks
Janwillem Kocks
NTNikolaos Tzanakis
Nikolaos Tzanakis
NSNikolaos Siafakas
Nikolaos Siafakas
TMThys van der Molen
Thys van der Molen

20 May 2012 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
ITIoanna G Tsiligianni
Ioanna G Tsiligianni
TMThys van der Molen
Thys van der Molen
DMDespoina Moraitaki
Despoina Moraitaki
ILIlaine Lopez
Ilaine Lopez
JKJanwillem Kocks
Janwillem Kocks
NTNikolaos E Tzanakis
Nikolaos E Tzanakis
Health status provides valuable information, complementary to spirometry and improvement of health status has become an important treatment goal in COPD management. We compared the usefulness and validity of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ), two simple questionnaires, in comparison with the St. George Respiratory Questionnaire (SGRQ).

16 November 2018 in npj Primary Care Respiratory Medicine
Verified
Journal Article
Open access
PDF file
JKJanwillem Kocks
Janwillem Kocks
HCHenry Chrystyn
Henry Chrystyn
JPJob van der Palen
Job van der Palen
MTMike Thomas
Mike Thomas
LYLouisa Yates
Louisa Yates
MMMathieu Molimard
Mathieu Molimard
Inhaled medications are the cornerstone of treatment and management of asthma and COPD. However, inhaler device errors are common among patients and have been linked with reduced symptom control, an increased risk of exacerbations, and increased healthcare utilisation. These observations have prompted GINA (Global INitiative for Asthma) and GOLD (Global initiative for chronic Obstructive Lung Disease) to recommend regular assessment of inhaler technique in a bid to improve therapeutic outcomes. To better define the relationship between device errors and health outcomes (clinical outcomes, quality of life, and healthcare utilisation) in asthma and COPD, we conducted a systematic review of the literature, with a particular focus on the methods used to assess the relationship between device errors and outcomes. Sixteen studies were identified (12 in patients with asthma, one in patients with COPD, and three in both asthma and COPD) with varying study designs, endpoints, and patient populations. Most of the studies reported that inhalation errors were associated with worse disease outcomes in patients with asthma or COPD. Patients who had a reduction in errors over time had improved outcomes. These findings suggest that time invested by healthcare professionals is vital to improving inhalation technique in asthma and COPD patients to improve health outcomes.

26 April 2011 in Primary Care Respiratory Journal
Verified
Journal Article
Closed access
JKJanwillem Kocks
Janwillem Kocks
GAGuus M Asijee
Guus M Asijee
ITIoanna G Tsiligianni
Ioanna G Tsiligianni
HKHuib Kerstjens
Huib Kerstjens
TMThys van der Molen
Thys van der Molen

25 April 2024 in Advances in Therapy
Verified
Journal Article
Open access
PDF file
DSDave Singh
Dave Singh
MHMeiLan K. Han
MeiLan K. Han
NHNathaniel M. Hawkins
Nathaniel M. Hawkins
JHJohn Hurst
John Hurst
JKJanwillem Kocks
Janwillem Kocks
CGChris P. Gale
Chris P. Gale
Chronic obstructive pulmonary disease (COPD) constitutes a major global health burden and is the third leading cause of death worldwide. A high proportion of patients with COPD have cardiovascular disease, but there is also evidence that COPD is a risk factor for adverse outcomes in cardiovascular disease. Patients with COPD frequently die of respiratory and cardiovascular causes, yet the identification and management of cardiopulmonary risk remain suboptimal owing to limited awareness and clinical intervention. Acute exacerbations punctuate the progression of COPD in many patients, reducing lung function and increasing the risk of subsequent exacerbations and cardiovascular events that may lead to early death. This narrative review defines and summarises the principles of COPD-associated cardiopulmonary risk, and examines respiratory interventions currently available to modify this risk, as well as providing expert opinion on future approaches to addressing cardiopulmonary risk.

1 November 2010 in Respiratory Medicine
Verified
Journal Article
Closed access
ARAyalu A. Reda
Ayalu A. Reda
DKDaniel Kotz
Daniel Kotz
JKJanwillem Kocks
Janwillem Kocks
GWGeertjan Wesseling
Geertjan Wesseling
CSConstant P. van Schayck
Constant P. van Schayck